FOLH1 and prostate cancer: To confirm the specific binding of ADVC001 to PSMA in a cellular system, we assessed the accumulation of 212Pb-ADVC001 in prostate cancer cells with or without PSMA expression in steady-state and kinetic experiments (Fig. 1C).